APA (7th ed.) Citation

Forns, J., Dudukina, E., Hägg, D., Szentkúti, P., Gembert, K., Plana, E., . . . Rebordosa, C. (2022). Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden. Neurology and Therapy, 11(4), 1659. https://doi.org/10.1007/s40120-022-00396-y

Chicago Style (17th ed.) Citation

Forns, Joan, et al. "Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden." Neurology and Therapy 11, no. 4 (2022): 1659. https://doi.org/10.1007/s40120-022-00396-y.

MLA (9th ed.) Citation

Forns, Joan, et al. "Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden." Neurology and Therapy, vol. 11, no. 4, 2022, p. 1659, https://doi.org/10.1007/s40120-022-00396-y.